Spots Global Cancer Trial Database for MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors

Official Title: Pilot Study of a Wearable EEG Headband as a Meditation Device for Breast Cancer Survivors

Study ID: NCT06274034

Conditions

Breast Carcinoma

Interventions

Electronic Health Record Review

Medical Device Usage and Evaluation

Meditation Therapy

Survey Administration

Study Description

Brief Summary: This early phase I trial evaluates the feasibility and impact of a meditation headband system (MUSE-S) for breast cancer survivors. Anxiety and insomnia are among the most common distresses in breast cancer survivors during and after chemotherapy, in part due to the side effects of chemotherapy, fear of cancer coming back, progression of the cancer, and uncertainty of the future. These distresses impair patients' well-being and quality of life (QOL) in general, and their cancer treatment adherence and effectiveness in particular. Meditation has been demonstrated to be an effective management tool of stress and anxiety and is given the highest level of evidence (grade A) in the systematic review-based guidelines by the Society of Integrative Medicine. The portable, interactive, electroencephalographic (EEG) Muse headband guided meditation has been shown to improve fatigue, QOL, and stress in newly diagnosed breast cancer patients. The MUSE-S Headband System may decrease anxiety and insomnia among breast cancer survivors.

Detailed Description: PRIMARY OBJECTIVES: I. To evaluate the frequency of use of meditation (a stress management technique) among breast cancer survivors. II. To evaluate the feasibility of a wearable EEG headband, MUSE S, together with smartphone or tablet application (app) to guide breast cancer survivors' interactive meditation and sleep support. III. To measure the impact of interactive meditation and sleep support through MUSE S among breast cancer survivors during or after chemotherapy on improving symptoms of anxiety and insomnia. OUTLINE: Patients wear the MUSE S headband to bed every night for 8 weeks and meditate using the MUSE phone app during day hours for at least 5 minutes over 8 weeks.